期刊文献+

脱氢表雄酮抑制成骨细胞凋亡的实验研究 被引量:4

原文传递
导出
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2005年第12期844-845,共2页 Chinese Journal of Obstetrics and Gynecology
基金 国家自然科学基金资助项目(30472259) 上海市卫生局青年基金资助项目(044Y06)
  • 相关文献

参考文献6

二级参考文献23

  • 1Arnett TR,Dempster DW.A comparative study of disaggregted chick and rat osteoclasts in vitro:effects of calcitonin and prostaglandins[J].Endocrinology,1987,120:602.
  • 2Lacey D,Timms E,Tan H,et al.Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation [J].Cell,1998,93:165.
  • 3Lamberts SW,van den Beld AW,van der Lely AJ.The endocrinology of aging [J].Science,1997,278:419.
  • 4Inoue S,Urano T,Ogawa S.Molecular cloning of rat efp:expression and regulation in primary osteoblasts[J].Biochem Biophys Res Commun,1999,261(2):412.
  • 5Kameda T,Mano H,Kumegawa M.Techniques for purification of rabbit osteoclasts and analysis of their functions [J].Nippon Yakurigaku Zasshi ,1997,109(2):75.
  • 6Lindunger A,Mackay CA,EK-RYlander B.Histochemistry and biochemistry of tartrate-resistant acid phosphatase and Tartrate-resistant acid adenosine triphosphatase in bone,bone marrow and spleen:impilcations for osteoclast ontogeny[J].Bone Miner,1990,10:109.
  • 7Wong B,RhoJJ,Arronet J,etal.TRANCE is anovel ligand of the tumor necrosis factor receptor family that activates C-Jun N-termind kinase in T cell[J].J Biol Chem,1997,272:25190.
  • 8Anderson D,Maraskovsky E,Billingsley W,et al.A homologue of the TNF receptor and its ligand enhance T cell growth and dendritic cell function[J].Nature,1997,390:175.
  • 9Kong Y,Yoshida H,Sarosi L,et al.OPGL is a key regulator of osteoclastogenesis,lymphocyte development and lymph node organogenesis[J].Nature,1999,397:315.
  • 10Yasuda H,Dhima N,Nakagawa N,et al.Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis inhibitory factor and is identical to TRANCE RANK [J].Proc Natl Acad Sci USA,1998,95:3597.

共引文献58

同被引文献41

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部